Drawing for MYOFORSA

USPTO serial 79231825

MYOFORSA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
HARDY LUDLOW, TARAH KIM
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MYOFORSA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of central nervous system diseases; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of metabolism diseases; sanitary products for medical purposes, namely, alcohol, antiseptics and anesthetics; implantable medicines for the prevention and treatment of diabetes; implantable medicines for the prevention and treatment of cardiovascular diseases; implantable medicines for the prevention and treatment of central nervous system diseases; implantable medicines for the prevention and treatment of cancer; implantable medicines for the prevention and treatment of metabolism diseases; disinfectants for all-purpose use; medicated compressesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 12, 2021DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Apr 11, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 25, 2019FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 9, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 9, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 9, 2018MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Oct 9, 2018ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 9, 2018OP.TOPPOSITION TERMINATED NO. 999999—
Oct 9, 2018OP.SOPPOSITION SUSTAINED NO. 999999—
Jul 14, 2018RFNPREFUSAL PROCESSED BY IB—
Jun 27, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 22, 2018OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Jun 22, 2018OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Jun 21, 2018OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jun 19, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 30, 2018NPUBNOTICE OF PUBLICATION—
May 22, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 16, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 16, 2018DOCKASSIGNED TO EXAMINER—
May 16, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 11, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 10, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance